Chinese investors to buy SciClone Pharmaceuticals, firm valued at $605m

Chinese investors to buy SciClone Pharmaceuticals, firm valued at $605m

Image from SciClone website.

Ascendent Capital partnersBank of China Group InvestmentBoying InvestmentsCDH Investments.GL Capital ManagementSciClone Pharmaceuticals

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.